Evolus Inc is getting support for its legal battle with AbbVie Inc’s Allergan over a rival to the Botox wrinkle treatment from dermatologists tired of an “800-pound gorilla” controlling the beauty market.

More than four dozen dermatologists have written to the U.S. International Trade Commission, asking it to allow Botox rival Jeuveau to stay on the US market. A trade judge in July recommended a 10-year ban on imports of Korean-made Jeuveau, saying it was created using a stolen formula.

Read the full article at bloomberg.com